MONDAY, July 18, 2022 — The number of HIV tests and cases identified among children aged 1 to 14 years decreased at the start of the COVID-19 pandemic, according to research published in the July 15 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Ariana M. Traub, M.P.H., from the U.S. Agency for International Development in Washington, D.C., and colleagues examined changes in HIV testing and diagnoses among persons aged 1 to 14 years in 22 U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)-supported countries during Oct. 1, 2019, to Sept. 30, 2020, representing the two fiscal quarters before the COVID-19 pandemic (Q1 and Q2) and two quarters after the pandemic began (Q3 and Q4).
The researchers found that PEPFAR supported 4,312,343 HIV tests and identified 74,658 children living with HIV (CLHIV) during October 2019 to September 2020. A similar number of HIV tests was performed during Q1 and Q2, while the number decreased 40.1 percent from Q2 to Q3 and then increased 19.7 percent from Q3 to Q4. Among children aged 1 to 14 years, the number of HIV cases identified increased 7.4 percent from Q1 to Q2, decreased 29.4 percent from Q2 to Q3, and then increased 3.3 percent from Q3 to Q4. From Q1 to Q4, testing in outpatient departments decreased 21 percent, while testing from other strategies increased during the same period, including a 38 percent increase in mobile testing. Overall, 61.3 percent of the tests and 60.9 percent of cases were among children aged 5 to 14 years.
“These findings provide important information for countries and programs on the most effective strategies for identifying CLHIV during the COVID-19 pandemic,” the authors write.
© 2022 HealthDay. All rights reserved.
Posted July 2022
Further Support and Information on COVID-19
More news resources
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.